Actelion sales and marketing update

ATLN launched its Tracleer bosentan oral endothelin receptor antagonist to treat pulmonary arterial hypertension (PAH) in the U.S. Genentech Inc. (DNA, South San Francisco, Calif.) has U.S. co-promo...